Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Scientia Psychiatrica Scientific Journal of Dermatology and Venereology
Pham Uyen
Unknown Affiliation
Health Professions Medicine & Pharmacology Neuroscience Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analysis of Risk Factors that Influence Patient Compliance in Taking Antiretroviral Drugs for HIV/AIDS Treatment in Hanoi Hospital, Vietnam Pham Uyen; Mariette Jackson
Scientific Journal of Dermatology and Venereology Vol. 2 No. 2 (2024): Scientific Journal of Dermatology and Venereology
Publisher : Phlox Institute: Indonesian Medical Research Organization

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59345/sjdv.v2i1.132

Abstract

Introduction: HIV/AIDS infection remains a global public health problem, with antiretroviral therapy (ARV) being key in its management. Patient adherence to ARV treatment is critical to achieving viral suppression and preventing drug resistance. This study aims to analyze the risk factors that influence patient compliance in taking ARV drugs at Hanoi Hospital, Vietnam. Methods: This study used a cross-sectional analytical observational design involving 300 HIV/AIDS patients undergoing ARV therapy at Hanoi Hospital. Data was collected through structured interviews and patient medical records. Data analysis used logistic regression to identify risk factors associated with patient compliance. Results: The research results showed that the level of patient compliance with ARV treatment was 72%. Risk factors that are significantly associated with patient compliance are: Low social support (OR=2.3; p=0.02), Limited knowledge about HIV/AIDS and ARV treatment (OR=1.8; p=0.04), Stigma and discrimination related to HIV/ AIDS (OR=1.7; p=0.03), Severe side effects of ARV drugs (OR=1.6; p=0.03), Complexity of ARV treatment regimens (OR=1.5; p=0.04). Conclusion: This study found that patient adherence to ARV treatment at Hanoi Hospital was influenced by various factors, including social support, knowledge about HIV/AIDS and ARVs, stigma and discrimination, drug side effects, and the complexity of the treatment regimen. Interventions targeting these risk factors may help improve patient compliance and achieve more optimal treatment outcomes.
Preventing Cognitive Decline in Late-Life Depression: A Longitudinal Study on the Efficacy of Omega-3 Fatty Acid Supplementation in Older Adults in Palembang, Indonesia Sony Sanjaya; Febria Suryani; Pham Uyen; Maria Rodriguez; Muhammad Yoshandi
Scientia Psychiatrica Vol. 6 No. 4 (2025): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v6i2.190

Abstract

Introduction: Late-life depression (LLD) is a prevalent condition in older adults and a significant risk factor for cognitive decline and dementia. In Indonesia, with its aging population and specific dietary patterns, understanding interventions for LLD-associated cognitive impairment is crucial. Omega-3 polyunsaturated fatty acids (PUFAs) offer potential neuroprotective benefits. This study aimed to assess the efficacy of long-term omega-3 PUFA supplementation in mitigating cognitive decline among older adults with LLD in Palembang, Indonesia. Methods: This 24-month, randomized, double-blind, placebo-controlled trial was conducted in Palembang. Three hundred sixty older adults (aged ≥60 years) with a current DSM-5 diagnosis of Major Depressive Disorder (MDD) and subjective cognitive complaints were randomized (1:1) to receive either daily oral supplementation of 2.2 grams of omega-3 PUFAs (containing 1320 mg eicosapentaenoic acid [EPA] and 880 mg docosahexaenoic acid [DHA]) or a matched placebo (corn oil). The primary outcome was the change in the Indonesian version of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog-INA) score over 24 months. Secondary outcomes included changes in the Montreal Cognitive Assessment-Indonesian version (MoCA-INA), Geriatric Depression Scale (GDS-30), Instrumental Activities of Daily Living (IADL), serum Brain-Derived Neurotrophic Factor (BDNF), and high-sensitivity C-Reactive Protein (hs-CRP). Results: Over 24 months, the omega-3 group exhibited significantly less decline on the ADAS-Cog-INA compared to the placebo group (mean difference: -2.1 points; 95% CI: -3.8 to -0.4; p=0.018). Statistically significant benefits for the omega-3 group were also observed in MoCA-INA scores (mean difference: 1.5 points; p=0.025) and GDS-30 scores (mean difference: -2.5 points; p=0.011). BDNF levels increased significantly in the omega-3 group relative to placebo (p=0.008), while hs-CRP levels showed a non-significant trend towards reduction (p=0.072). Conclusion: Long-term supplementation with 2.2 g/day of EPA-rich omega-3 PUFAs resulted in a modest but statistically significant attenuation of cognitive decline and improvement in depressive symptoms in older adults with LLD in Palembang. These findings suggest that omega-3 PUFAs could be a valuable adjunctive therapeutic strategy in this specific Southeast Asian population.
Co-Authors Febria Suryani Maria Rodriguez Mariette Jackson Muhammad Yoshandi Sony Sanjaya